Free tool
FAERS Monitor: Pred Mild
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017100 or its brand name (Pred Mild, Prednisolone Acetate). Reports on generic versions are filed under their own applications.
Reports
8,532
Serious
4,015
47% of reports
Hospitalization
1,576
Death reported
456
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- treatment failure1,252
- drug ineffective777
- recalled product administered763
- no adverse event651
- off label use554
- eye pain482
- eye irritation320
- vision blurred287
- fatigue261
- headache241
- diarrhoea225
- condition aggravated210
- pain210
- ocular hyperaemia205
- pyrexia187
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 17 |
| 2005 | 31 |
| 2006 | 35 |
| 2007 | 70 |
| 2008 | 131 |
| 2009 | 52 |
| 2010 | 75 |
| 2011 | 70 |
| 2012 | 165 |
| 2013 | 94 |
| 2014 | 131 |
| 2015 | 247 |
| 2016 | 489 |
| 2017 | 282 |
| 2018 | 412 |
| 2019 | 482 |
| 2020 | 1,641 |
| 2021 | 439 |
| 2022 | 510 |
| 2023 | 596 |
| 2024 | 631 |
| 2025 | 673 |
| 2026 | 1,259 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,627 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| recalled product administeredSignal | 763 | 214.3 | 199.6 | 148,886 |
| treatment failureSignal | 1,252 | 37.8 | 35.9 | 44,330 |
| eye painSignal | 482 | 21.2 | 19.5 | 9,218 |
| eye irritationSignal | 320 | 13.8 | 12.4 | 3,768 |
| ocular hyperaemiaSignal | 205 | 10.7 | 9.3 | 1,787 |
| no adverse eventSignal | 651 | 8.9 | 8.3 | 4,571 |
| vision blurredSignal | 287 | 5.2 | 4.6 | 963 |
| condition aggravated | 210 | 1.7 | 1.5 | 61 |
| off label use | 554 | 1.6 | 1.4 | 116 |
| drug ineffective | 777 | 1.5 | 1.4 | 117 |
| pyrexia | 187 | 1.3 | 1.2 | 15 |
| headache | 241 | 0.9 | 0.8 | 1 |
| diarrhoea | 225 | 0.9 | 0.8 | 5 |
| pain | 210 | 0.8 | 0.7 | 6 |
| fatigue | 261 | 0.8 | 0.7 | 10 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.